LIM
HZNP

Leavell Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Leavell Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,000
Closed -$347K – 482
2023
Q3 		$347K Sell
3,000
-1,032
-26% -$111K 0.02% 378
2023
Q2 		$415K Buy
4,032
+622
+18% +$65.6K 0.03% 356
2023
Q1 		$372K Sell
3,410
-2,840
-45% -$314K 0.03% 360
2022
Q4 		$711K Sell
6,250
-1,241
-17% -$103K 0.05% 280
2022
Q3 		$464K Sell
7,491
-250
-3% -$17.5K 0.04% 316
2022
Q2 		$617K Buy
7,741
+274
+4% +$25.9K 0.05% 285
2022
Q1 		$786K Buy
7,467
+201
+3% +$19.6K 0.05% 266
2021
Q4 		$783K Sell
7,266
-1,060
-13% -$116K 0.05% 269
2021
Q3 		$912K Sell
8,326
-1,152
-12% -$120K 0.07% 232
2021
Q2 		$872K Hold
9,478
– – 0.07% 223
2021
Q1 		$872K Buy
9,478
+18
+0.2% +$1.52K 0.07% 223
2020
Q4 		$692K Hold
9,460
– – 0.06% 242
2020
Q3 		$735K Buy
9,460
+1,300
+16% +$89.4K 0.06% 217
2020
Q2 		$454K Sell
8,160
-2,000
-20% -$85.6K 0.04% 269
2020
Q1 		$301K Buy
10,160
+160
+2% +$5.41K 0.03% 283
2019
Q4 		$362K Hold
10,000
– – 0.03% 299
2019
Q3 		$272K Hold
10,000
– – 0.03% 337
2019
Q2 		$241K Hold
10,000
– – 0.03% 350
2019
Q1 		$264K Hold
10,000
– – 0.03% 334
2018
Q4 		$195K Hold
10,000
– – 0.02% 348
2018
Q3 		$196K Hold
10,000
– – 0.02% 370
2018
Q2 		$166K Hold
10,000
– – 0.02% 367
2018
Q1 		$142K Buy
+10,000
New +$148K 0.02% 369

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Leavell Investment Management's HZNP Position: Q4 2023 in Review

Leavell Investment Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 3,000 shares — an estimated $347K sold.

Leavell Investment Management first reported a position in HZNP in Q1 2018 and held it in 23 quarters. The position peaked at $912K in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Leavell Investment Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Leavell Investment Management sold 3,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $347K.
  • Leavell Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2018 and held it in 23 quarters.
  • Leavell Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $912K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Leavell Investment Management's 13F filing for Q4 2023, filed 23 Jan 2024.